Owner Sloan-Kettering Institute for Cancer Research Merck HDAC Research, LLC

Inventors Kelly, W Kevin; Miller, Thomas A.; Chiao, Judy H.; Richon, Victoria M.

Agent Cullen & Co

Pub. Number AU-B-2007203525

Parent 2003213684

Filing date 26 July 2007

Wipo publication date 16 August 2007

Acceptance publication date 28 August 2008

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/13 (2006.01) - Amines, e.g. amantadine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/4706 (2006.01) - 4-Aminoquinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups